Cleared Traditional

K102617 - AUDIT MICROCV CARDIAC MARKERS LINEARITY...

K102617 is the FDA 510(k) clearance for AUDIT MICROCV CARDIAC MARKERS LINEARITY... by Aalto Scientific, Ltd.. It is a Class 1 Chemistry device (product code JJY) cleared through the Traditional 510(k) pathway after a 122-day FDA review.

K102617 · Aalto Scientific, Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2011
Decision
122d
Days
Class 1
Risk

K102617 is an FDA 510(k) clearance for the AUDIT MICROCV CARDIAC MARKERS LINEARITY SET. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Aalto Scientific, Ltd. (Carlsbad, US). The FDA issued a Cleared decision on January 10, 2011 after a review of 122 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Aalto Scientific, Ltd. devices

Submission Details

510(k) Number K102617 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2010
Decision Date January 10, 2011
Days to Decision 122 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
34d slower than avg
Panel avg: 88d · This submission: 122d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 320
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K102617.
RANDOX LIQUID URINE CONTROL LEVELS 2 AND 3
K110904 · Randox Laboratories, Ltd. · Sep 2011
ELECSYS PRECICONTROL VARIA 3
K111506 · Roche Diagnostics · Jul 2011
THERMO SCIENTIFIC MAS OMNI-IMMUNE, MAS OMNI IMMUNE PRO
K110616 · Microgenics Corp. · Jun 2011
PRECICONTROL CLINCHEM MULTI 1 AND 2
K102016 · Roche Diagnostics · Sep 2010
NOVA MAX PLUS GLOCOSE AND B-KETONE CONTROL SOLUTION-MID, HIGH
K101633 · Nova Biomedical Corp. · Aug 2010
ELECSYS PRECICONTROL MULTIMARKER
K102157 · Roche Diagnostics · Aug 2010